Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
T3S Technologies
AddedFeb 18, 2024
UpdatedJun 18, 2026
T3S Technologies

T3S Technologies

Angel

T3S Technologies: A leading protein expression service provider prioritizing work-life balance.

HQ
Salt Lake City, UT, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize protein expression, T3S Technologies specializes in providing advanced genetic and biochemical solutions for challenging protein expressions. The company leverages its proprietary technologies and deep expertise to offer world-renowned services in protein expression, particularly in bacteria. T3S Technologies aims to bridge the gap in understanding complex proteins, making it a crucial partner for biotech firms and research institutions focused on genetic and protein research.

T3S Technologies has garnered attention from notable investors and industry leaders due to its groundbreaking work in genetic engineering. The company's achievements include the successful expression of previously difficult-to-express proteins, which has significant implications for medical and scientific research. By prioritizing innovation and maintaining a strong commitment to work-life balance, T3S Technologies has established itself as a pivotal player in the biotech industry, driving advancements that have a lasting impact on scientific progress.

T3S Technologies - Similar Companies

Triplebar logo

Triplebar

triplebar.com

3T Biosciences logo

3T Biosciences

3tbiosciences.com

Tierra Biosciences logo

Tierra Biosciences

TigerGene logo

TigerGene

DtoR logo

DtoR

dtorinc.com

CasTag Biosciences logo

CasTag Biosciences

Future Fields logo

Future Fields

futurefields.io

Glyphic Biotechnologies logo

Glyphic Biotechnologies

glyphic.bio

Proteios Technology logo

Proteios Technology

proteios.com

TRex Bio logo

TRex Bio

trex.bio

Innovative Genetics logo

Innovative Genetics

Transomic Technologies logo

Transomic Technologies

ExpressCells logo

ExpressCells

Terra Bioforge logo

Terra Bioforge

terrabioworks.com

Alltrna logo

Alltrna

alltrna.com

T3S Technologies - Quick Facts

Who are T3S Technologies' competitors?

Companies similar to T3S Technologies include Triplebar, 3T Biosciences, Tierra Biosciences and TigerGene.

When was T3S Technologies founded?

T3S Technologies was founded in 2015.

Where is T3S Technologies' headquarters located?

T3S Technologies' headquarters is located in Salt Lake City, UT, US.

When was T3S Technologies' last funding round?

T3S Technologies' most recent funding round was for $225k (USD) in June 2016.

How much has T3S Technologies raised to-date?

As of Jun 20, 2016, T3S Technologies has raised a total of $225k (USD).

How many employees does T3S Technologies have?

T3S Technologies has 5 employees as of Feb 4, 2024.

T3S Technologies - Classification

Industry
  • Professional Service Companies
Technology
  • Biotech
Geographic Exposure
  • Global
Customer
  • Enterprise
Main Product
  • Protein Expression
Tags
  • API
  • Consulting
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software